Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapeutic antisense and ribozymes

J J Rossi1

  • 1Center for Molecular Biology and Gene Therapy, Loma Linda University School of Medicine, California, USA.

British Medical Bulletin
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A critical assessment of the potential of short interfering RNA therapeutics.

Drug discovery today. Technologies·2014
Same author

Current progress in the development of RNAi-based therapeutics for HIV-1.

Gene therapy·2011
Same author

Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivo.

Gene therapy·2009
Same author

Stem cells, ribozymes and HIV.

Gene therapy·2009
Same author

Innate immunity confounds the clinical efficacy of small interfering RNAs (siRNAs).

Gene therapy·2009
Same author

Cholesterol paves the way for topically applied viricides.

Cell host & microbe·2009

Antisense technology uses DNA oligonucleotides or ribozymes to block specific gene expression, offering a promising therapeutic approach for various diseases. Advances in delivery systems ensure its future clinical application.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biotechnology

Background:

  • Gene expression is naturally regulated by antisense mechanisms.
  • Antisense technology offers sequence-specific inhibition of gene expression.

Purpose of the Study:

  • To explore the therapeutic potential of antisense DNA oligonucleotides and catalytic antisense RNAs (ribozymes).
  • To highlight the clinical applicability of antisense technology.

Main Methods:

  • Designing antisense DNA oligonucleotides and ribozymes.
  • Utilizing sequence-specific pairing to inhibit target nucleic acids.

Main Results:

  • Antisense molecules can functionally inhibit gene expression with high specificity.

Related Experiment Videos

  • Various viral and non-viral delivery schemes have been developed.

    • Conclusions:

    • Antisense technology holds significant potential for treating a wide range of diseases.
    • The development of delivery systems makes clinical use of antisense molecules highly probable.